Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19
GERIA-COVID
2 other identifiers
observational
700
1 country
1
Brief Summary
Statement :
- The emerging Coronavirus 2019 (COVID-19) disease, linked to the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pathogen, has been spreading worldwide since December 2019, affecting millions of people and causing hundreds of thousands of deaths, particularly among the elderly.
- The first epidemiological evidence available reveals a different expression of the disease in the elderly, associated with a high risk of delayed diagnosis and implementation of protective measures and a particularly high morbidity and mortality, especially among the frailest.
- To date, there is no effective model for predicting the severity of COVID-19 in an individual. The investigators hypothesize that there are specificities of COVID-19 in the elderly, both etiological, diagnostic and prognostic, all of which are not yet known and understood.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2020
CompletedFirst Submitted
Initial submission to the registry
September 8, 2020
CompletedFirst Posted
Study publicly available on registry
September 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedDecember 20, 2021
December 1, 2021
2.8 years
September 8, 2020
December 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (14)
Medical history and co-morbidities
listing of medical history and co-morbidities data provided by the physician and the family during hospitalization
baseline
The physical examination data, and reports of relevant investigations data provided by the physician and the family during hospitalization
The demographic characteristics are age, sex, marital status, place of life, career, presence of un/formal assistance, …
baseline
Electrocardiography QT Interval
all electrocardiograms performed during hospitalization
baseline
Number of different therapeutic classes
Number of different therapeutic classes taken per day.
baseline
Comprehensive Geriatric Assessment (CGA)
Comprehensive geriatric assessment (CGA) is defined as a multidisciplinary diagnostic and treatment process that identifies medical, psychosocial, and functional capabilities of an older adult in order to develop a coordinated plan to maximize overall health with aging. CGA is based on the premise that a systematic evaluation of frail older persons by a team of health professionals may identify a variety of treatable health problems and lead to better health outcomes.
baseline
Biological parameters
Characterization of the COVID-19 impact on the biological parameters evaluated by blood test.
baseline
Medical imaging results
Assessment of lesion extension (percent) with medical imaging results (thoracic scan)
baseline
Diagnosis of COVID-19
Recovery of the diagnosis method (PCR or thoracic scan)
baseline
Length of hospitalization
at the 3-month follow-up
Number of death from any cause
at the 3-month follow-up
Reports of relevant investigations data provided by the physician and the family during the two-month telephone follow-up
The demographic characteristics are age, sex, marital status, place of life, career, presence of un/formal assistance, …
at the 3-month follow-up
Length of hospitalization
at the 12-month follow-up
Number of death from any cause
at the 12-month follow-up
Reports of relevant investigations data provided by the physician and the family during the two-month telephone follow-up
The demographic characteristics are age, sex, marital status, place of life, career, presence of un/formal assistance, …
at the 12-month follow-up
Eligibility Criteria
All consecutive patients meeting the eligibility criteria over the study period.
You may qualify if:
- Hospitalization in the Geriatric unit of the University Hospital (UH) of Angers from 15/03/2020 and until the closure of the COVID-19 geriatric sector
You may not qualify if:
- Opposition to the use of the information collected for research purposes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Angers University Hospital
Angers, 49933, France
Related Publications (1)
Briere O, Otekpo M, Asfar M, Gautier J, Sacco G, Annweiler C; GERIA-COVID study group. Initial functional disability as a 1-year prognostic factor in geriatric patients hospitalized with SARS-CoV-2 infection. PLoS One. 2023 Jul 27;18(7):e0289297. doi: 10.1371/journal.pone.0289297. eCollection 2023.
PMID: 37498909DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cédric ANNWEILER, MD, PhD
University Hospital, Angers
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 12 Months
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2020
First Posted
September 23, 2020
Study Start
March 15, 2020
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
December 20, 2021
Record last verified: 2021-12